[서울=뉴스핌] Reporter Choi Won-jin = The French government has decided to temporarily suspend the first dose of the Ile-de-France vaccine in the metropolitan area, including Paris, from February, as the French government did not receive the amount of vaccine for COVID-19 in time.
The European Union (EU) has decided to introduce a new system that can block vaccine exports as part of its efforts to secure vaccine supplies as the supply of vaccines is less than expected.
 |
| [뉴욕 로이터=뉴스핌] Reporter Choi Won-jin = A nurse is vaccinating Modena’s Corona 19 vaccine at the vaccination room at the Bronx Bathgate Post Office in New York, New York, USA. 2021.01.10 |
According to Reuters on the 28th (local time), the first corona19 vaccination in the Ile de France region of France, scheduled for early February, has been postponed to the first week of March. This is because Pfizer’s vaccine supply is tight.
Those who received the first vaccination within January can get the second vaccination right away, but it is not known when a new first vaccination will begin.
According to Reuters sources, French public health officials have issued instructions to stop the first dose at hospitals in Paris on February 2nd. However, it was announced that the second vaccination could be continued.
Moder and supply are also insufficient. The French Ministry of Health said the quantity of modders or vaccines expected to be received in February was also 25% less than expected.
As Pfizer and Modena’s supply of vaccines to the EU declined more than expected, the EU began securing the supply of vaccines.
Sources from Reuters said that the EU will introduce a system to monitor the exports of vaccines produced in 27 member countries and to block exports when vaccines are not supplied in time. Pharmaceutical companies producing vaccines in EU member states should report their export plans.
Pfizer vaccine shipments to the UK and Canada, for example, are produced in Belgium. The EU Commission said it requested the Belgian federal pharmaceutical authorities to visit the production plant of AstraZene.
AstraZeneca said it could deliver only 60% of its expected volume in the first quarter, but approval to use AstraZeneca will be issued on the 29th.
The EU will get the system up and running within a few days and it will be implemented during the first quarter of this year. The position is that it will consider extending the system deadline if necessary.